Tomoharu Yoshizumi

Tomoharu Yoshizumi

Auto-generated profile, based on publicly available information

Tomoharu Yoshizumi

Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2011 in Transplantation
Verified
Journal Article
Closed access
HUHideaki Uchiyama
Hideaki Uchiyama
YMYohei Mano
Yohei Mano
ATAkinobu Taketomi
Akinobu Taketomi
YSYuji Soejima
Yuji Soejima
TYTomoharu Yoshizumi
Tomoharu Yoshizumi
YMYoshihiko Maehara
Yoshihiko Maehara
Background. A novel immunosuppression protocol using rituximab and plasma exchange treatment was developed for ABO-incompatible living donor liver transplantation (ABO-I LDLT). The aim of this study was to investigate the kinetics of anti-blood type isoagglutinin titers and the number of blood B lymphocytes in ABO-I LDLT with the new protocol and their impact on the outcomes after ABO-I LDLT. Methods. Fifteen patients underwent ABO-I LDLT plus splenectomy with the new protocol between November 2005 and December 2010, and their data were retrospectively analyzed. Results. CD19-positive lymphocytes in the blood rapidly disappeared after rituximab treatment and began to recover approximately 6 months later. Anti-blood type isoagglutinin titers were lowered by pretransplant plasma exchange (23∼212→21∼28). Although the anti-donor blood type isoagglutinin titers remained consistently low after transplantation in comparison to the pretreatment levels, they persisted long after LDLT, whereas posttransplant biopsy specimens showed sustained A/B antigens on the graft livers. ABO-I hepatitis C virus-positive patients were prone to acceleration of hepatitis C viremia and cytomegalovirus antigenemia in comparison to the control patients. Conclusions. Although the new protocol for ABO-I LDLT yielded great success with 100% graft survival, the acceptable anti-blood type isoagglutinin titers just before LDLT, and its application to hepatitis C-positive patients must be determined.

1 October 2014
Verified
Journal Article
Closed access
JMJun Muto
Jun Muto
KSKen Shirabe
Ken Shirabe
TYTomoharu Yoshizumi
Tomoharu Yoshizumi
TIToru Ikegami
Toru Ikegami
SAShinichi Aishima
Shinichi Aishima
YMYoshihiko Maehara
Yoshihiko Maehara

18 May 2004
Verified
Journal Article
Closed access
MSMitsuo Shimada
Mitsuo Shimada
HIHideki Ijichi
Hideki Ijichi
YYYusuke Yonemura
Yusuke Yonemura
NHNoboru Harada
Noboru Harada
SSSatoko Shiotani
Satoko Shiotani
YMYoshihiko Maehara
Yoshihiko Maehara

1 June 2016
Verified
Journal Article
Closed access
SIShinji Itoh
Shinji Itoh
TYTomoharu Yoshizumi
Tomoharu Yoshizumi
KKKoichi Kimura
Koichi Kimura
HOHirohisa Okabe
Hirohisa Okabe
NHNorifumi Harimoto
Norifumi Harimoto
YMYoshihiko Maehara
Yoshihiko Maehara

15 May 2012 in Transplantation
Verified
Journal Article
Closed access
TTTakeo Toshima
Takeo Toshima
ATAkinobu Taketomi
Akinobu Taketomi
TIToru Ikegami
Toru Ikegami
TFTakasuke Fukuhara
Takasuke Fukuhara
HKHiroto Kayashima
Hiroto Kayashima
YMYoshihiko Maehara
Yoshihiko Maehara
Right lobe (RL) grafts without middle hepatic vein for living donor liver transplantation (LDLT) result in congestion of recipients' livers and sometimes in unfavorable postoperative course. This study aimed to evaluate the feasibility of our new V5-drainage-preserved RL (VP-RL) graft. Based on a review of 49 donors' livers in a retrospective study using three-dimensional reconstruction-computed tomography volumetry, hepatic vein draining segment 4 (V4) anatomy was classified into three types: inferior V4 dominant (A); superior V4 dominant (B); and umbilical vein to left hepatic vein dominant (C). Differences in functional graft volume (GV) and remnant liver volume (RV) between VP-RL and modified RL (M-RL) grafts with all three types were evaluated. In a prospective study of actual 15 LDLT, the outcome of venous reconstruction and postoperative parameters with VP-RL grafts compared with M-RL grafts was analyzed. In the retrospective study using three-dimensional reconstruction-computed tomography volumetry, in types B and C, functional GV of VP-RL was larger than that of M-RL (P<0.05) without impaired donors' functional RV, whereas functional RV in VP-RL was significantly decreased in type A (P<0.05). In the prospective study of actual 15 LDLT, using VP-RL with types B and C, size and number of venous reconstructions, and functional GV and postoperative parameters, such as postoperative serum total bilirubin levels and ascites volume, were significantly improved compared with those using M-RL (P<0.05). Using preoperative V4 anatomical classification, VP-RL graft procurement is a valuable strategy in RL-LDLT to improve postoperative course of both recipients and donors.

1 May 2015
Verified
Journal Article
Closed access
KTKazuki Takeishi
Kazuki Takeishi
TMTakashi Maeda
Takashi Maeda
ETEiji Tsujita
Eiji Tsujita
YYYo-Ichi Yamashita
Yo-Ichi Yamashita
NHNoboru Harada
Noboru Harada
YMYoshihiko Maehara
Yoshihiko Maehara